Royalty Pharma plc monthly returns
Royalty Pharma plc has averaged 0.86% a month with dividends reinvested, and risen in 55% of months, through November 17, 2026. The table lists the most recent months; the chart, the last 5 years.
Month by month#
Data provided bySource: Twelve Data| Month | Path | Total return |
|---|---|---|
| Nov 2026 | +2.6% | |
| Oct 2026 | +15.1% | |
| Sep 2026 | -5.0% | |
| Aug 2026 | +5.5% | |
| Jul 2026 | +4.2% | |
| Jun 2026 | +0.6% | |
| May 2026 | +11.8% | |
| Apr 2026 | +4.4% | |
| Mar 2026 | +3.8% | |
| Feb 2026 | +11.4% | |
| Jan 2026 | +7.9% | |
| Dec 2025 | -3.4% | |
| Nov 2025 | +7.2% | |
| Oct 2025 | +6.4% | |
| Sep 2025 | -1.9% | |
| Aug 2025 | -1.6% | |
| Jul 2025 | +2.1% | |
| Jun 2025 | +9.6% | |
| May 2025 | +0.9% | |
| Apr 2025 | +5.4% | |
| Mar 2025 | -7.5% | |
| Feb 2025 | +7.2% | |
| Jan 2025 | +23.8% | |
| Dec 2024 | -4.3% | |
| Nov 2024 | -0.4% | |
| Oct 2024 | -4.6% | |
| Sep 2024 | -2.5% | |
| Aug 2024 | +3.8% | |
| Jul 2024 | +6.8% | |
| Jun 2024 | -3.8% | |
| May 2024 | -0.3% | |
| Apr 2024 | -8.8% | |
| Mar 2024 | +0.1% | |
| Feb 2024 | +7.6% | |
| Jan 2024 | +1.1% | |
| Dec 2023 | +3.8% | |
| Nov 2023 | +1.5% | |
| Oct 2023 | -1.0% | |
| Sep 2023 | -9.0% | |
| Aug 2023 | -4.3% | |
| Jul 2023 | +2.1% | |
| Jun 2023 | -6.1% | |
| May 2023 | -6.3% | |
| Apr 2023 | -2.4% | |
| Mar 2023 | +0.5% | |
| Feb 2023 | -8.0% | |
| Jan 2023 | -0.8% | |
| Dec 2022 | -10.1% | |
| Nov 2022 | +4.4% | |
| Oct 2022 | +5.3% | |
| Sep 2022 | -3.9% | |
| Aug 2022 | -3.5% | |
| Jul 2022 | +3.4% | |
| Jun 2022 | +2.2% | |
| May 2022 | -2.9% | |
| Apr 2022 | +9.3% | |
| Mar 2022 | -0.8% | |
| Feb 2022 | -1.4% | |
| Jan 2022 | +0.4% | |
| Dec 2021 | +0.2% | |
| Nov 2021 | +1.0% | |
| Oct 2021 | +9.4% | |
| Sep 2021 | -6.5% | |
| Aug 2021 | +1.6% | |
| Jul 2021 | -6.8% | |
| Jun 2021 | +2.2% | |
| May 2021 | -8.4% | |
| Apr 2021 | +0.9% | |
| Mar 2021 | -6.3% | |
| Feb 2021 | -0.6% | |
| Jan 2021 | -6.1% | |
| Dec 2020 | +17.5% | |
| Nov 2020 | +16.5% | |
| Oct 2020 | -12.8% | |
| Sep 2020 | +2.1% | |
| Aug 2020 | -3.9% | |
| Jul 2020 | -11.3% | |
| Jun 2020since Jun 16 | +9.1% |
Monthly total return (since Dec 2021)#
Royalty Pharma plc returns by calendar month#
Every month of every year since 2020, one tick per year on a shared scale; the dark bar is the month's average. Total returns, dividends reinvested.
November 2026 so far: +2.58% — 4th of 7 Novembers since 2020 at the last close; the average November returned +5.0%.
| Month | −25%0+25% | Average | Median | Up | Best | Worst |
|---|---|---|---|---|---|---|
| Jan | +4.4% | +0.7% | 67% | +23.8% 2025 | -6.1% 2021 | |
| Feb | +2.7% | +3.3% | 50% | +11.4% 2026 | -8.0% 2023 | |
| Mar | -1.7% | -0.3% | 50% | +3.8% 2026 | -7.5% 2025 | |
| Apr | +1.5% | +2.6% | 67% | +9.3% 2022 | -8.8% 2024 | |
| May | -0.9% | -1.6% | 33% | +11.8% 2026 | -8.4% 2021 | |
| Jun | +0.8% | +1.4% | 67% | +9.6% 2025 | -6.1% 2023 | |
| Jul | +0.1% | +2.1% | 71% | +6.8% 2024 | -11.3% 2020 | |
| Aug | -0.3% | -1.6% | 43% | +5.5% 2026 | -4.3% 2023 | |
| Sep | -3.8% | -3.9% | 14% | +2.1% 2020 | -9.0% 2023 | |
| Oct | +2.6% | +5.3% | 57% | +15.1% 2026 | -12.8% 2020 | |
| Nov | +5.0% | +2.9% | 83% | +16.5% 2020 | -0.4% 2024 | |
| Dec | +0.6% | -1.6% | 50% | +17.5% 2020 | -10.1% 2022 |
Methodology#
Monthly returns are total returns (dividends reinvested), computed from RPRX's split- and dividend-adjusted month-end closes. The table shows the most recent 120 months and the bar chart the most recent 60. See the year-by-year returns for the annual view. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Royalty Pharma plc's average monthly return?
- Royalty Pharma plc has averaged about 0.86% per month (dividends reinvested), positive in roughly 55% of months. The best month was Jan 2025 (+23.8%) and the worst was Oct 2020 (-12.8%).
